| The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein S Ghosh, S Bhowmik, S Majumdar, A Goswami, J Chakraborty, S Gupta, ... International journal of cancer 147 (10), 2934-2947, 2020 | 100 | 2020 |
| Spatiotemporal uncoupling of microRNA-mediated translational repression and target RNA degradation controls microRNP recycling in mammalian cells M Bose, B Barman, A Goswami, SN Bhattacharyya Molecular and cellular biology, 2017 | 51 | 2017 |
| MicroRNA exporter HuR clears the internalized pathogens by promoting pro‐inflammatory response in infected macrophages A Goswami, K Mukherjee, A Mazumder, S Ganguly, I Mukherjee, ... EMBO molecular medicine 12 (3), e11011, 2020 | 27 | 2020 |
| Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy M Gangar, S Goyal, D Raykar, P Khurana, AM Martis, A Goswami, ... Bioorganic Chemistry 119, 105549, 2022 | 18 | 2022 |
| AVA-NP-695 selectively inhibits ENPP1 to activate STING pathway and abrogate tumor metastasis in 4T1 breast cancer syngeneic mouse model A Goswami, B Deb, S Goyal, A Gosavi, M Mali, AM Martis, P Khurana, ... Molecules 27 (19), 6721, 2022 | 15 | 2022 |
| Combatting intracellular pathogens using bacteriophage delivery A Goswami, PR Sharma, R Agarwal Critical Reviews in Microbiology 47 (4), 461-478, 2021 | 15 | 2021 |
| Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages PR Sharma, AA Dravid, YC Kalapala, VK Gupta, S Jeyasankar, ... Biomaterials Advances 133, 112612, 2022 | 13 | 2022 |
| Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles E George, A Goswami, T Lodhiya, P Padwal, S Iyer, I Gauttam, L Sethi, ... Biomaterials Advances 139, 213003, 2022 | 9 | 2022 |
| Leishmania survives by exporting miR-146a from infected to resident cells to subjugate inflammation S Ganguly, B Ghoshal, I Banerji, S Bhattacharjee, S Chakraborty, ... Life Science Alliance 5 (6), 2022 | 9 | 2022 |
| A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C S Ghosh, J Chakraborty, A Goswami, S Bhowmik, S Roy, A Ghosh, ... RNA biology 17 (9), 1352-1363, 2020 | 4 | 2020 |
| 1333 Development of IMGS-001, a novel anti-PD-L1/PD-L2 dual specific, multi-functional antibody, to treat immune excluded tumors C Gagliardi, F Pericle, A Salameh, P Blezinger, M Curran Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3* | 2022 |
| AVA-ADR-001 Suppresses Tumor Growth and Induces Anti-tumor Immunity by Selectively Inhibiting ADAR1 p150 A Kulkarni, A Goswami, B Deb, A Mohanty, S Goyal, K Singh, R Yadav, ... | 2 | 2023 |
| AVA-NP-695, a potent and selective ENPP1 inhibitor, abrogates tumor metastasis in 4T1 syngeneic tumor model and demonstrates strong tumor regression when combined with radiation A Kulkarni, A Goswami, S Goyal, P Khurana, I Ghoshal Cancer Research 83 (7_Supplement), 3244-3244, 2023 | 2 | 2023 |
| Leishmania Hijacks microRNA Import-Export Machinery of Infected Macrophage and Survives by Cross-Communicating Host miR-146a to Subjugate HuR and miR-122 in Neighbouring cells S Ganguly, B Ghoshal, I Banerji, S Bhattacharjee, S Chakraborty, ... bioRxiv, 2021.09. 06.459146, 2021 | 2 | 2021 |
| 1334 AVA-ADR-001 supresses tumor growth and induces anti-tumor immunity by selectively inhibiting ADAR1 p150 AB Papaiah, A Goswami, S Goyal, K Singh, P Khurana, A Kulkarni Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Discovery of a potential first-in-class Za targeted small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy A Goswami, S Goyal, K Singh, P Khurana, B Deb, A Kulkarni Cancer Research 84 (6_Supplement), 4484-4484, 2024 | | 2024 |
| 864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation A Goswami, S Goyal, P Khurana, K Singh, I Ghoshal, A Kulkarni Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model A Goswami, B Deb, S Goyal, P Khurana, K Singh, A Kulkarni Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Development of a novel ADAR1 inhibitor as a potent immunomodulator for the treatment of solid tumors A Kulkarni, A Goswami, S Goyal, K Singh, P Khurana, I Ghoshal Cancer Research 83 (7_Supplement), 3095-3095, 2023 | | 2023 |
| Cause and consequence of differential compartmentalization of miRNA and interacting protein factors in infected macrophage cells A Goswami Department of Bio-Chemistry Calcutta University, 2019 | | 2019 |
